In contrast, FGFR2 and FGFR3 were not significantly correlated with any subgroup of breast cancer cell lines, whereas FGFR4 expression was elevated in HER2 and luminal cell lines (Supplementary Fig. 3a–d). Here, ERBB2 is linked to breast carcinoma.